1. Involvement of the MEN1 Gene in Hormone-Related Cancers: Clues from Molecular Studies, Mouse Models, and Patient Investigations
    Razan Abou Ziki et al, 2020, Endocrines CrossRef
  2. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study
    Guoqiao Zheng et al, 2021, BMC Cancer CrossRef
  3. Neoplasia endocrina múltiple tipo 1 y cáncer de mama. Una asociación a tener en cuenta
    Sandra Herranz-Antolín et al, 2018, Endocrinología, Diabetes y Nutrición CrossRef
  4. The 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors
    Paraskevi Xekouki et al, 2021, Gigantism and Acromegaly CrossRef
  5. Calcitonin-Producing Pancreatic Tumor
    Silvia Uccella, 2022, Endocrine Pathology CrossRef
  6. Primary thyroid paraganglioma mimicking medullary thyroid carcinoma: A case report
    XING YU et al, 2015, Oncology Letters CrossRef
  7. The recurrent p.(Pro540Ser) MEN1 genetic variant should be considered nonpathogenic: A case report
    Carles Villabona et al, 2021, American Journal of Medical Genetics Part A CrossRef
  8. A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1
    Ko Harada et al, 2019, Endocrine Journal CrossRef
  9. Incidental finding of MEN-1 syndrome during staging and follow-up of breast carcinoma
    Bernardo Conde Maria et al, 2020, BMJ Case Reports CrossRef
  10. Multiple endocrine neoplasia type 1 and breast cancer. An association to consider
    Sandra Herranz-Antolín et al, 2018, Endocrinología, Diabetes y Nutrición (English ed.) CrossRef
  11. Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1
    Nobumasa Ohara et al, 2017, Respiratory Medicine Case Reports CrossRef
  12. Paraganglioma of the Thyroid Gland
    Ahmad S. Alharthi et al, 2024, Saudi Journal of Otorhinolaryngology Head and Neck Surgery CrossRef
  13. Beyond the “3 Ps”: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1
    Steven G. Waguespack, 2022, Frontiers in Endocrinology CrossRef
  14. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
    Laura Pierotti et al, 2023, Frontiers in Endocrinology CrossRef
  15. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors
    Paraskevi Xekouki et al, 2019, Hormone and Metabolic Research CrossRef
  16. Co‐occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes
    Vincent Larouche et al, 2019, Endocrinology, Diabetes & Metabolism CrossRef
  17. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas
    Samuel M O'Toole et al, 2015, Endocrine-Related Cancer CrossRef
  18. Coincidental Occurrence of Multiple Endocrine Neoplasia Type 1 and Breast Cancer in a Young Saudi Girl: A Case Study and Genetic Analysis
    Amal Alhefdhi et al, 2023, Cureus CrossRef
  19. Calcitonin-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Multiple Endocrine Neoplasia Type 1
    Umer A. Ansari et al, 2017, AACE Clinical Case Reports CrossRef
  20. Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives
    Fatemeh Khatami et al, 2018, Biomarker Insights CrossRef
  21. Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
    Romain Teinturier et al, 2021, Breast Cancer Research and Treatment CrossRef
  22. Considerations for Comprehensive Assessment of Genetic Predisposition in Familial Breast Cancer
    Henry Lynch et al, 2015, The Breast Journal CrossRef
  23. Calcitonin-Producing Pancreatic Tumor
    Silvia Uccella, 2022, Encyclopedia of Pathology CrossRef